Macomics Announces Updated Data of the ENIGMAC Drug Discovery Platform and The Role of Macrophages in Fibrotic Disease

Macomics, Ltd. announces that it has validated its ENIGMAC^™ platform in macrophage mediated antifibrotic therapy. The drug discovery platform is designed to discover therapeutic targets and unlock disease specific target biology.